Company Overview of Xalud Therapeutics, Inc.
Xalud Therapeutics, Inc. develops therapies for the treatment of neuro-inflammatory diseases. The company offers XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. It also researches on the applicability of XT-101 for multiple sclerosis and amyotrophic lateral sclerosis. The company was founded in 2009 and is based in San Francisco, California.
30 Hill Street
San Francisco, CA 94110
Founded in 2009
Key Executives for Xalud Therapeutics, Inc.
Xalud Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Xalud Therapeutics, Inc., please visit www.xaludthera.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.